ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison

被引：18
作者：
Myllynen, Paivi [1 ]
Kummu, Maria [1 ,2 ]
Sieppi, Elina [1 ]
机构：
[1] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland
[2] Univ Oulu, Ctr Arctic Med, Thule Inst, FIN-90014 Oulu, Finland
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2010年 / 6卷 / 11期
关键词：
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN EXPRESSION; LIMITS FETAL DISTRIBUTION; MULTIDRUG-RESISTANCE; PHOSPHOGLYCOPROTEIN ABCB1; DRUG TRANSPORTERS; GENE-EXPRESSION; MOUSE PLACENTA; RAT PLACENTA; BCRP/ABCG2;
D O I：
10.1517/17425255.2010.514264
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Areas covered in this review: Comprehensive literature searches were done using PubMed (until June 2010) to identify publications on ABCB1 and ABCG2 expression in placenta and fetal tissues in human, mouse, rat, guinea-pig and rabbit. What the reader will gain: In this review, we aim to provide an overview of the current knowledge on the ABCB1 and ABCG2 transporter expression profiles in the placenta and fetal tissues in humans relative to other species. Take home message: The available information on ABCB1 and ABCG2 temporal expression profiles in placenta and fetus indicates rather good correlation among human, mouse and rat although some specific differences have been reported. However, at this point no detailed comparisons or comparative functional data are available. Detailed knowledge on the expression patterns and functional activity of ABCB1 and ABCG2 transporters placenta and developing embryo/fetus in different species could possibly help the interspecies extrapolation.
引用
收藏
页码：1385 / 1398
页数：14
相关论文
共 50 条
  • [31] Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates
    Sébastien Goutal
    Oliver Langer
    Sylvain Auvity
    Karine Andrieux
    Christine Coulon
    Fabien Caillé
    Philippe Gervais
    Salvatore Cisternino
    Xavier Declèves
    Nicolas Tournier
    Drug Delivery and Translational Research, 2018, 8 : 536 - 542
  • [32] Effects of Gambogenic Acid on the Function and Expression of ABCB1 and ABCG2 Transporters in Human HepG2 Liver Cancer cells
    Xu, Qianqian
    Li, Jing
    Guo, Junsong
    Sun, Jing
    Chen, Weidong
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (04): : 677 - 684
  • [33] Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates
    Goutal, Sebastien
    Langer, Oliver
    Auvity, Sylvain
    Andrieux, Karine
    Coulon, Christine
    Caille, Fabien
    Gervais, Philippe
    Cisternino, Salvatore
    Decleves, Xavier
    Tournier, Nicolas
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2018, 8 (03) : 536 - 542
  • [34] Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
    Shi, Zhi
    Tiwari, Amit K.
    Shukla, Suneet
    Robey, Robert W.
    Kim, In-Wha
    Parmar, Smitaben
    Bates, Susan E.
    Si, Qiu-Sheng
    Goldblatt, Curtis S.
    Abraham, Ioana
    Fu, Li-Wu
    Ambudkar, Suresh V.
    Chen, Zhe-Sheng
    BIOCHEMICAL PHARMACOLOGY, 2009, 77 (05) : 781 - 793
  • [35] Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications
    Sakurai, A
    Tamura, A
    Onishi, Y
    Ishikawa, T
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (14) : 2455 - 2473
  • [36] Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP)
    Yang, Danwen
    Kathawala, Rishil J.
    Chufan, Eduardo E.
    Patel, Atish
    Ambudkar, Suresh V.
    Chen, Zhe-Sheng
    Chen, Xiang
    FUTURE ONCOLOGY, 2014, 10 (11) : 1827 - 1841
  • [37] Vodobatinib overcomes cancer multidrug resistance by attenuating the drug efflux function of ABCB1 and ABCG2
    Li, Yen-Ching
    Lin, Bing-Huan
    Murakami, Megumi
    Wu, Yu-Shan
    Hung, Tai-Ho
    Chen, Chin-Chuan
    V. Ambudkar, Suresh
    Wu, Chung-Pu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 988
  • [38] Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer
    Omori, Miwako
    Noro, Rintaro
    Seike, Masahiro
    Matsuda, Kuniko
    Hirao, Mariko
    Fukuizumi, Aya
    Takano, Natsuki
    Miyanaga, Akihiko
    Gemma, Akihiko
    THORACIC CANCER, 2022, 13 (15) : 2142 - 2151
  • [39] ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
    Schulz, Julia A.
    Hartz, Anika M. S.
    Bauer, Bjorn
    PHARMACOLOGICAL REVIEWS, 2023, 75 (05) : 815 - 853
  • [40] Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments
    To, Kenneth K. W.
    Hu, Miao
    Tomlinson, Brian
    PHARMACOGENOMICS, 2014, 15 (08) : 1091 - 1104
12345